TriReme catheter gets approval in Japan

GliderXtreme is designed to address complex lesions in the peripheral vasculature

TriReme catheter gets approval in Japan

Singapore: TriReme Medical's Japanese partner Century Medical has received Shonin approval, the approval to market in Japan, for the GliderXtreme PTA catheter for the treatment of peripheral arterial blockages, a widespread disease impacting over 200 million people worldwide.

With its low-profile nitinol shaft and proprietary "slide-lock" design, GliderXtreme is designed to address complex lesions in the peripheral vasculature. The innovative features of GliderXtreme produce a balloon catheter with exceptional pushability and crossability, providing physicians with the confidence needed to begin and finish even the toughest cases.

"Peripheral arterial disease is a growing health care concern in Asia. GliderXtreme was custom designed to meet the clinical needs and exacting standards of the Japanese marketplace. We are proud to receive this regulatory approval," stated Dr Eitan Konstantino, president and CEO of TriReme. "This milestone represents yet another step in the Asia-focused expansion strategy of TriReme."

"Representing the latest in peripheral balloon technology, GliderXtreme will enable Japanese physicians to treat complex lesions both above and below the knee," explained Mr Akira Hoshino, president and CEO, CMI. "This is the second product approved as a result of our collaboration with TriReme Medical."